GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vidipha Central Pharmaceutical JSC (STC:VDP) » Definitions » Construction In Progress

Vidipha Central Pharmaceutical JSC (STC:VDP) Construction In Progress : ₫0.00 Mil (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Vidipha Central Pharmaceutical JSC Construction In Progress?


Vidipha Central Pharmaceutical JSC Construction In Progress Historical Data

The historical data trend for Vidipha Central Pharmaceutical JSC's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vidipha Central Pharmaceutical JSC Construction In Progress Chart

Vidipha Central Pharmaceutical JSC Annual Data
Trend
Construction In Progress

Vidipha Central Pharmaceutical JSC Semi-Annual Data
Construction In Progress

Vidipha Central Pharmaceutical JSC Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Vidipha Central Pharmaceutical JSC Business Description

Traded in Other Exchanges
N/A
Address
184/2 Le Van Sy Street, Ward 10, Phu Nhuan District, Ho Chi Minh City, VNM
Vidipha Central Pharmaceutical JSC operates as a drug manufacturer in Vietnam. The business activities of the company includes trading, importing, and exporting cosmetics and pharmaceutical products, producing medicines, and production of raw materials and chemicals.

Vidipha Central Pharmaceutical JSC Headlines

No Headlines